VANCOUVER, British Columbia — Yehia Hashad, MD, Allergan’s senior vice president and head of global development, discusses a recent study that found the company’s sustained release bimatoprost implant provided good IOP control and visual field preservation in patients with open-angle glaucoma.
Uncategorized